UNICA IRIS Institutional Research Information System

DEMELIA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 108.357
NA - Nord America 5.726
AS - Asia 2.641
SA - Sud America 355
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 117.142
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 104.691
US - Stati Uniti d'America 5.666
NL - Olanda 1.873
CN - Cina 1.077
SG - Singapore 960
UA - Ucraina 546
DE - Germania 330
SE - Svezia 300
BR - Brasile 267
FI - Finlandia 224
VN - Vietnam 203
GB - Regno Unito 166
FR - Francia 133
HK - Hong Kong 90
KR - Corea 50
IN - India 39
BD - Bangladesh 35
AR - Argentina 34
RU - Federazione Russa 33
CA - Canada 26
ID - Indonesia 26
JP - Giappone 23
MX - Messico 20
PK - Pakistan 19
IQ - Iraq 18
EC - Ecuador 15
TR - Turchia 15
UZ - Uzbekistan 14
BE - Belgio 13
MA - Marocco 13
VE - Venezuela 12
PH - Filippine 11
KE - Kenya 10
ZA - Sudafrica 10
SA - Arabia Saudita 9
AT - Austria 8
CO - Colombia 8
PL - Polonia 8
IL - Israele 7
ES - Italia 6
MY - Malesia 6
EG - Egitto 5
JO - Giordania 5
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
DK - Danimarca 4
LB - Libano 4
MU - Mauritius 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EU - Europa 3
IE - Irlanda 3
IR - Iran 3
NG - Nigeria 3
NP - Nepal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
BB - Barbados 1
BG - Bulgaria 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 117.142
Salva come PNG Salva come JPEG
Città #
Cagliari 103.277
Amsterdam 1.869
Uta 1.136
Fairfield 549
Singapore 477
Woodbridge 426
Ashburn 402
Chandler 385
Houston 337
Ann Arbor 335
Jacksonville 288
San Jose 273
Boardman 271
Wilmington 247
Dallas 243
Dearborn 222
Nyköping 220
Cambridge 215
Beijing 194
Seattle 194
Helsinki 130
Los Angeles 99
Santa Clara 97
Hefei 90
Nanjing 87
Hong Kong 84
Lauterbourg 78
New York 76
Shanghai 66
Boston 65
Ho Chi Minh City 64
Seoul 46
The Dalles 46
Buffalo 41
Hanoi 38
Nanchang 38
Milan 37
Guangzhou 35
San Diego 32
Shenyang 32
Munich 31
São Paulo 30
Hebei 27
Jiaxing 27
Verona 26
Changsha 24
London 22
Tokyo 21
Orange 20
Toronto 19
Auburn Hills 16
Dong Ket 16
Mountain View 16
Redwood City 16
Redondo Beach 15
Tianjin 15
Jinan 14
Orem 14
Tashkent 14
Brussels 13
Frankfurt am Main 13
Norwalk 13
Turku 13
Council Bluffs 12
Kunming 12
Rome 12
Manchester 11
Ningbo 11
Washington 11
Brooklyn 10
Da Nang 9
Jakarta 9
Zhengzhou 9
Ansbach 8
Brasília 8
Chennai 8
Chicago 8
Mexico City 8
Porto Alegre 8
San Francisco 8
Sassari 8
Biên Hòa 7
Guayaquil 7
Nairobi 7
Phoenix 7
Wuhan 7
Columbus 6
Düsseldorf 6
Lahore 6
Rio de Janeiro 6
Taizhou 6
Atlanta 5
Caxias do Sul 5
Dhaka 5
Erbil 5
Haiphong 5
Hangzhou 5
Johannesburg 5
Nuremberg 5
Perugia 5
Totale 113.556
Salva come PNG Salva come JPEG
Nome #
Proteomic investigation of whole saliva in Wilson's disease 4.315
null 3.544
Bipolar disorders and Wilson's disease 3.248
The burden of depressive and bipolar disorders in celiac disease 2.925
Coeliac disease and psychiatric comorbidity: epidemiology, pathophysiological mechanisms, quality-of-life, and gluten-free diet effects 2.750
Value of histochemical stains for copper in the diagnosis of Wilson's disease 2.738
Late onset Wilson's disease 2.554
Premature vascular deterioration in young patients affected by Wilson's disease: a pilot study 2.543
Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? 2.434
Homogeneous magnetic resonance imaging of brain abnormalities in bipolar spectrum disorders comorbid with Wilson's disease 2.402
alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis 2.391
Mutation analysis of the ATP7B gene in a new group of Wilson's disease patients: Contribution to diagnosis. 2.358
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 2.337
Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena 2.297
A Top-Down proteomic study of the whole saliva of subjects affected by Wilson disease reveals qualitative and quantitative alterations of the S100A8 and S100A9 proteins 2.253
Psychiatric comorbidity in Wilson’s disease 2.246
Potential biomarker discover of the Wilson’s disease by top-down proteomic investigation of whole saliva 2.095
Quality of life and psychiatric symptoms in wilson's disease: The relevance of bipolar disorders 2.056
Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience 1.920
The relationship between copper and steatosis in Wilson's disease 1.847
TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses 1.844
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D 1.826
Fine structure of hepatic sinusoids in Wilson’s disease. A scanning electron microscopic study 1.775
Non-invasive assessment of silent liver fibrosis in patients with systemic sclerosis 1.772
A randomized controlled trial of sequential pegylated interferon-alpha and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B 1.752
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 1.730
null 1.710
Reversibility of fibrosis in Wilson disease 1.630
Uneven hepatic copper distribution in Wilson's disease 1.612
Kayser-Fleischer ring in Wilson's disease: a cohort study 1.551
Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease 1.521
Brain MR spectroscopy in the evaluation of Wilson's disease: Correlation with clinical status and response to therapy 1.482
Secondary RBD in a patient affected by chronic hepatic encephalopathy: a case report. 1.473
HBV and HCV infections in Wilson's disease patients: Copper overload could be protective? 1.462
null 1.366
Dynamic 99mTc-HIDA hepatobiliary scintigraphy in vanishing bile duct syndrome 1.309
Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD 1.284
Peginterferon-alpha-2a plus adefovir vs. peginterferon alpha-2a for 48 weeks in hbeag-negative chronic hepatitis B: Preliminary 24-week results of the peg for B randomized multicenter trial 1.231
Usefulness of dynamic hepatobiliary scintigraphy in Wilson's disease 1.221
Wilson’s disease with late onset 1.204
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study. 1.136
Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis 1.007
HFE gene mutations and Wilson's disease in Sardinia 1.001
Tolerability of Peg interferon-alpha 2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency 998
Resolved Psychosis after Liver Transplantation in a Patient with Wilson's Disease 990
Syncitial giant cell hepatitis. A case report 988
Massive haemosiderosis in Wilson’s disease 981
[Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy]. FT Effetto a breve termine della terapia con DL-carnitina per os ed L-carnitina e.v. nei pazienti uremici cronici in trattamento emodialitico. 980
A randomized controlled trial of pegylated interferon-alpha 2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B 961
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study 954
HFE gene mutations and Wilson's disease in Sardinia 949
Massive haemosiderosis in Wilson's disease - Reply 942
Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy 939
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 923
SEQUENTIAL PEGINTERFERON ALPHA-2A AND TELBIVUDINE OR VICE VERSA FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B: PRELIMINARY END-OF-TREATMENT RESULTS OF THE TEL-B-PEG RANDOMIZED TRIAL 917
Clinical features of Wilson's disease in Sardinia 847
Massive hepatic haemosiderosis in Wilson's disease 838
Interferon beta-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C 831
A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy 826
Dosage of the hepatic copper in the normal range in a patient affected by Wilson’s disease. 780
Wilson’s disease with late onset 745
Syncitial giant cell hepatitis: a new form of chronic liver disease 714
Peginterferon alpha-2a (40kD) monotherapy vs peginterferon alpha-2a and ribavirin in naive patients with chronic hepatitis C: Preliminary results of the SMIEC II trial in patients with early viral clearance on peginterferon monotherapy 683
Unusual evolution from overt autoimmune hypothyroidism to hyperthyroidism after IFN-α therapy for chronic hepatitis. 682
Ductular reaction and oval cell prolipheration in chronic hepatitis C. 670
Enhanced response to peginterferon-alpha-2a-based triple therapy in previously non-responsive chronic hepatitis C: Final results of pretty study RID E-8970-2010 638
Chronic viral hepatitis in Hiv + drug addicts 632
Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease 630
Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902-1983) 611
Computerized cranial tomography in presymptomatic and hepatic form of Wilson's disease 603
Final results of the SMIEC trial in natve patients with hepatitis C: Double therapy (peginterferonalfa2a+ribavirin) vs peginterferon monotherapy in early viral responders and vs triple therapy (peginterferon plus ribavirin plus amantadine) in early non responders 576
[Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis]. FT La precallicreina plasmatica (fattore Fletcher) nella cirrosi epatica. 563
Wilson's disease maps between the D13S169 and D13S173 loci 558
HCV transmission in family members of subjects with HCV related chronic liver disease 535
Predictive testing for Wilson's disease using tightly linked and flanking DNA markers 529
null 520
Diagnostic value of 24 hr urinary copper excretion after penicillamine challenge in the adult Wilson's disease patients. 512
Coagulazione, fibrinolisi e shunt porto-sistemico nelle epatopatie croniche 497
IS INTRAPULMONARY SHUNT IN CIRRHOTIC-PATIENTS CORRELATED WITH PORTACAVAL-SHUNT 484
HDL-cholesterol in chronic uremia during hemodialytic treatment 476
A randomized controlled trial of amantadine plus interferon alpha-2a vs interferon-alpha-2a in naive patients with chronic hepatitis C randomized based on early response to interferon alpha-2a alone. 464
Idiopathic adulthood ductopenia presenting with chronic recurrent cholestasis. A case report 457
Pseudo-porphyria cutanea tarda in patients hemodialyzed for chronic renal insufficiency. Clinical, metabolic and immunological aspect 438
Usefulness and limitations of determination of lactate dehydrogenase enzymes in the diagnosis of liver diseases 427
Transient elastography in patients with chronic autoimmune hepatitis: is a goog tool in evaluation of hepatic fibrosis? 393
The role of a double liver needle biopsy in the diagnosis of Wilson's disease. 377
Hypothalamo-pituitary-adrenal function in liver cirrhosis of viral etilogy 372
Diagnostic value of histochemical stains for copper in Wilson's disease 362
Efficacy of lamivudine in patients with antiHBe plus chronic active hepatitis B. 356
Efficacy and safety of long-term IFN therapy in active chronic hepatitis D: Six years of sustained response to the treatment. Case report. 353
ABNORMAL PULMONARY EPITHELIAL PERMEABILITY IN LIVER-CIRRHOSIS 352
Serum ALT level, phlebotomy treatment and alpha-interferon therapy in chronic hepatitis C. 282
Totale 117.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.685
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.370 0 0 0 0 0 0 0 0 0 1.476 1.124 770
2021/20227.452 652 615 443 495 513 825 601 319 419 514 902 1.154
2022/20238.388 993 1.192 1.086 737 831 914 320 665 385 416 485 364
2023/20247.300 491 421 320 788 762 1.091 953 480 343 536 588 527
2024/20259.186 2.045 2.139 1.148 944 599 643 817 93 211 156 184 207
2025/20265.819 242 280 581 508 302 277 618 433 2.152 426 0 0
Totale 117.287